Hedge Fund - Wildcat Capital Management
Urogen Pharma Ltd. (URGN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $5,481,402 | 2.93% | 495,606 | $10.66 |
| 2 | 2024 - Q4 (2024-12-31) | $5,278,204 | 2.08% | 495,606 | $11.97 |
| 3 | 2024 - Q3 (2024-09-30) | $6,294,196 | 3.07% | 495,606 | $14.84 |
| 4 | 2024 - Q2 (2024-06-30) | $8,316,269 | 2.03% | 495,606 | $14.22 |
| 5 | 2024 - Q1 (2024-03-31) | $7,434,090 | 2.69% | 495,606 | $16.35 |
| 6 | 2023 - Q4 (2023-12-31) | $7,434,090 | 2.57% | 495,606 | $12.98 |
| 7 | 2023 - Q3 (2023-09-30) | $6,943,440 | 2.78% | 495,606 | $16.05 |
| 8 | 2023 - Q2 (2023-06-30) | $5,129,522 | 1.95% | 495,606 | $11.03 |
| 9 | 2023 - Q1 (2023-03-31) | $4,579,399 | 1.7% | 495,606 | $9.20 |
| 10 | 2022 - Q4 (2022-12-31) | $4,728,943 | 1.8% | 533,139 | $9.47 |
| 11 | 2022 - Q3 (2022-09-30) | $4,436,000 | 1.7% | 533,139 | $8.27 |
| 12 | 2022 - Q2 (2022-06-30) | $4,366,000 | 1.44% | 533,139 | $6.87 |
| 13 | 2022 - Q1 (2022-03-31) | $4,644,000 | 1.18% | 533,139 | $7.80 |
| 14 | 2021 - Q4 (2021-12-31) | $5,070,000 | 0.82% | 533,139 | $14.10 |
| 15 | 2021 - Q3 (2021-09-30) | $8,967,000 | 1.16% | 533,139 | $15.85 |
| 16 | 2021 - Q2 (2021-06-30) | $8,141,000 | 0.92% | 533,139 | $18.08 |
| 17 | 2021 - Q1 (2021-03-31) | $10,386,000 | 1.26% | 533,139 | $21.23 |
| 18 | 2020 - Q4 (2020-12-31) | $22,566,000 | 2.83% | 1,252,285 | $20.95 |
| 19 | 2020 - Q3 (2020-09-30) | $24,156,000 | 7.72% | 1,252,285 | $22.64 |
| 20 | 2020 - Q2 (2020-06-30) | $23,512,000 | 8.12% | 900,148 | $24.44 |
| 21 | 2020 - Q1 (2020-03-31) | $16,058,000 | 7.31% | 900,148 | $27.01 |
| 22 | 2019 - Q4 (2019-12-31) | $38,571,000 | 11.12% | 1,155,862 | $27.30 |
| 23 | 2019 - Q3 (2019-09-30) | $25,166,000 | 10.69% | 1,056,062 | $32.69 |
| 24 | 2019 - Q2 (2019-06-30) | $30,311,000 | 13.11% | 843,365 | $36.87 |
| 25 | 2019 - Q1 (2019-03-31) | $28,776,000 | 16.86% | 779,003 | $41.92 |
| 26 | 2018 - Q4 (2018-12-31) | $26,374,000 | 17.33% | 612,494 | $44.96 |
| 27 | 2018 - Q3 (2018-09-30) | $17,734,000 | 13.68% | 375,479 | $46.47 |
| 28 | 2018 - Q2 (2018-06-30) | $12,513,000 | 9.57% | 251,459 | $58.20 |
| 29 | 2018 - Q1 (2018-03-31) | $9,029,000 | 7.44% | 181,702 | $50.09 |
| 30 | 2017 - Q4 (2017-12-31) | $4,738,000 | 5.04% | 127,313 | $35.61 |
| 31 | 2017 - Q3 (2017-09-30) | $4,255,000 | 0.76% | 135,000 | $22.08 |
| 32 | 2017 - Q2 (2017-06-30) | $2,439,000 | 0.64% | 135,000 | $17.36 |
The displayed share prices are average quarterly stock market prices.